PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...
VIENNA — The Duet procedure, in which a monofocal or monofocal toric IOL is implanted into the capsular bag and an additive trifocal IOL is implanted into the sulcus, showed stable long-term outcomes ...
HONOLULU, Sept. 9, 2019 /PRNewswire/ -- Ophthalmological surgeons Tyrie Jenkins, M.D. and Jeffrey Peterson, M.D., Ph.D., of Jenkins Eye Care, now offer cataract ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio LAS VEGAS — The PanOptix trifocal IOL ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Jeffrey Horn, MD, of Nashville, Tenn.-based Vision for Life, will implant a PanOptix Trifocal Intraocular Lens in a patient Sept. 4. 1. Dr. Horn will complete what is believed to be the first ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients ...
Trifocal intraocular lenses (IOLs) represent the latest in premium lens technology. They are tiny, artificial lenses that are implanted into the eye during a cataract or lens replacement procedure.
PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback